Show simple item record

dc.contributor.authorRadzevičiūtė, Eivina
dc.contributor.authorMalyško-Ptašinskė, Veronika
dc.contributor.authorKulbacka, Julita
dc.contributor.authorRembiałkowska, Nina
dc.contributor.authorNovickij, Jurij
dc.contributor.authorGirkontaitė, Irutė
dc.contributor.authorNovickij, Vitalij
dc.date.accessioned2023-09-18T16:21:11Z
dc.date.available2023-09-18T16:21:11Z
dc.date.issued2022
dc.identifier.issn1567-5394
dc.identifier.other(crossref_id)140196157
dc.identifier.urihttps://etalpykla.vilniustech.lt/handle/123456789/113404
dc.description.abstractElectroporation is a pulsed electric field (PEF) induced phenomenon, which effectiveness varies dependent on pulse parameters. This work focuses on nano-electrochemotherapy with bleomycin and doxorubicin to derive protocols as effective as European Standard Operating Procedures on Electrochemotherapy (ESOPE), which employ conventional microsecond range pulses. As a model, murine Lewis lung carcinoma (LLC1) cell line was used. The effects of pulse duration (100–500 ns), PEF amplitude (6–10 kV/cm) and pulse repetition frequency (10 kHz, 100 kHz, 1 MHz) were studied. A total of 75 ns protocol variations have been used. For detection of cell permeabilization, Yo-Pro-1 and flow cytometry were employed. Cell viability was evaluated 24-, 48-, or 72-hours post-electroporation. Nanosecond parametric protocols resulting in comparable treatment efficiency as ESOPE (1.3 kV/cm × 100 μs × 8) have been proposed. It was shown that high-frequency nanosecond electrochemotherapy with bleomycin or doxorubicin could be an alternative for established ESOPE protocols.eng
dc.formatPDF
dc.format.extentp. 1-12
dc.format.mediumtekstas / txt
dc.language.isoeng
dc.relation.isreferencedbyScience Citation Index Expanded (Web of Science)
dc.relation.isreferencedbyScopus
dc.rightsLaisvai prieinamas internete
dc.source.urihttps://talpykla.elaba.lt/elaba-fedora/objects/elaba:139237487/datastreams/MAIN/content
dc.titleNanosecond electrochemotherapy using bleomycin or doxorubicin: Influence of pulse amplitude, duration and burst frequency
dc.typeStraipsnis Web of Science DB / Article in Web of Science DB
dcterms.references59
dc.type.pubtypeS1 - Straipsnis Web of Science DB / Web of Science DB article
dc.contributor.institutionValstybinis mokslinių tyrimų institutas Inovatyvios medicinos centras
dc.contributor.institutionVilniaus Gedimino technikos universitetas
dc.contributor.institutionWroclaw Medical University
dc.contributor.facultyElektronikos fakultetas / Faculty of Electronics
dc.subject.researchfieldT 001 - Elektros ir elektronikos inžinerija / Electrical and electronic engineering
dc.subject.researchfieldN 010 - Biologija / Biology
dc.subject.vgtuprioritizedfieldsMC0505 - Inovatyvios elektroninės sistemos / Innovative Electronic Systems
dc.subject.ltspecializationsL105 - Sveikatos technologijos ir biotechnologijos / Health technologies and biotechnologies
dc.subject.enESOPE
dc.subject.ennanosecond electroporation
dc.subject.enmembrane permeabilization
dc.subject.encancer
dc.subject.endrugs
dc.subject.enNsPEF
dc.subject.enhigh frequency
dcterms.sourcetitleBioelectrochemistry
dc.description.volumevol. 148
dc.publisher.nameElsevier
dc.publisher.cityLausanne
dc.identifier.doi140196157
dc.identifier.doi000863189300005
dc.identifier.doi10.1016/j.bioelechem.2022.108251
dc.identifier.elaba139237487


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record